Dr.Nigatu Tadesse Gebrehiwot is a researcher in pharmacology at the School of Pharmaceutical Sciences, Institute of Drug discovery and Development, Zhengzhou University. He has research interest in the broad topics of pharmacology, drug safety evaluation and clinical therapeutics, with special interest in translation oncology through the interplay of tumor metabolism and epigenetics in cancer drug resistance mechanism, and precision medicine through biomarkers development and metabolic targets.
Dr.Nigatu Tadesse Gebrehiwot is a researcher in pharmacology at the School of Pharmaceutical Sciences, Institute of Drug discovery and Development, Zhengzhou University. He has research interest in the broad topics of pharmacology, drug safety evaluation and clinical therapeutics, with special interest in translation oncology through the interplay of tumor metabolism and epigenetics in cancer drug resistance mechanism, and precision medicine through biomarkers development and metabolic targets.